Rcc market share breakdown for Cabo | EXEL Message Board Posts

EXEL   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  22736 of 22760  at  9/12/2019 9:41:58 AM  by

hbomb57108


 In response to msg 22735 by  JoeFlow
view thread

Re: Rcc market share breakdown for Cabo

 So I guesstimate a 35% market share in that 40% tki monotherapy population.----- I dont believe that 40% monotherapy tki market share will change that fast in community setting.  I would love to see if community setting docs have adopted cabo in first line or if it is mainly academic centers?
 
I also believe  checkmate 9er could be significant on cabo sales if the study can demonstrate differentiated activity vs the pembro/axitinib combo.
 
I believe like you they can drug those 1st line patients a long time and increasing that market share is bigger than most realize.   I also believe monotherapy cabo will still get a good portion of those patients back in second and third line monotherapy rechallenge imo. Mostly third line rechallenge though.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 215
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
22737 Re: Rcc market share breakdown for Cabo erniewerner 1 9/12/2019 10:07:31 AM
22741 Re: Rcc market share breakdown for Cabo enabeler 0 9/12/2019 12:36:40 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...